(Q71793298)
Statements
Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial (English)
Buckner CD
1 reference
M. C. Benyunes
C. Higuchi
A. York
C. Lindgren
J. A. Thompson
1 August 1995